SDHB Antibodies

Santa Cruz Biotechnology offers a broad range of SDHB monoclonal antibodies for studying succinate dehydrogenase complex subunit B (SDHB). SDHB monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SDHB plays a crucial role in the mitochondrial respiratory chain, contributing to cellular energy production and metabolism. Ongoing research has revealed SDHB's involvement in regulating reactive oxygen species, with significant implications for various pathologies, including certain types of cancer. Understanding SDHB function and regulation is essential for elucidating metabolic disorders and developing targeted therapies. Research into SDHB has uncovered its significance in mitochondrial function and cellular homeostasis. Current investigations continue to reveal new aspects of SDHB's role in both normal physiology and disease states. SDHB research has become increasingly important in understanding metabolic pathways and their disruption in various disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SDHB and its potential therapeutic applications.